The Asia Pacific Continuous Glucose Monitoring Device Market would witness market growth of 13.7% CAGR during the forecast period (2020-2026). As tested in many clinical studies, it has been found that diabetic patients with type 1 diabetes mellitus (T1DM) with continuous glucose monitoring have greater glycemic regulation relative to when using glucometer for daily blood glucose self-monitoring. The trend follows in children, as well as those who frequently use a CGM. The results in these children display better-glycosylated levels of hemoglobin (HbA1c) without an increased hyperglycemia frequency.
The latest CGM models have enabled the administration of electrochemical subcutaneous sensors based on glucose oxidase to measure glucose levels in the interstitial fluid. CGM apps may either show the patterns in blood glucose levels retrospectively by downloading the data or offer a real-time image of glucose levels via receiver displays. Many CGMs in real-time can provide patients, parents, or caregivers with an alert during current or pending glycemic visits to encourage timely blood glucose control.
Asia Pacific market is predicted to have the fastest growth over the projected period. Nearly 60 percent of the world's diabetic population lives in the Asia Pacific region, according to the Asian Diabetes Prevention Initiative. The high prevalence of the disease has spurred global demand development in developed countries such as India and China. In addition, increasing healthcare spending, extensive business activity, and supportive regulatory policies will have a positive effect on the development of this region's market.
Based on Component, the market is segmented into Sensors, Transmitters, and Receivers. Based on End User, the market is segmented into Hospitals, Homecare Settings and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Continuous Glucose Monitoring Device Market in Asia Pacific is expected to register a CAGR of 13.7% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, DexCom, Inc., Ypsomed AG, Senseonics Holdings, Inc., GlySens, Incorporated, A. Menarini Diagnostics Ltd. (The Menarini Group), Echo Therapeutics, Inc., Johnson and Johnson.
Scope of the Asia Pacific Continuous Glucose Monitoring Device Market Analysis
Market Segmentation:
By Component
- Sensors
- Transmitters and
- Receivers
By End User
- Hospitals
- Homecare Settings and
- Other End Users
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Abbott Laboratories
- Medtronic PLC
- Hoffmann-La Roche Ltd.
- Novo Nordisk A/S
- DexCom, Inc.
- Ypsomed AG
- Senseonics Holdings, Inc.
- GlySens, Incorporated
- Menarini Diagnostics Ltd. (The Menarini Group)
- Echo Therapeutics, Inc.
- Johnson and Johnson
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Continuous Glucose Monitoring Device Market, by Component
1.4.2 Asia Pacific Continuous Glucose Monitoring Device Market, by End User
1.4.3 Asia Pacific Continuous Glucose Monitoring Device Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Continuous Glucose Monitoring Device Market by Component
3.1 Asia Pacific Sensors Market by Country
3.2 Asia Pacific Transmitters Market by Country
3.3 Asia Pacific Receivers Market by Country
Chapter 4. Asia Pacific Continuous Glucose Monitoring Device Market by End-user
4.1 Asia Pacific Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 Asia Pacific Homecare Settings Market by Country
4.3 Asia Pacific Other End Users Market by Country
Chapter 5. Asia Pacific Continuous Glucose Monitoring Device Market by Country
5.1 China Continuous Glucose Monitoring Device Market
5.1.1 China Continuous Glucose Monitoring Device Market by Component
5.1.2 China Continuous Glucose Monitoring Device Market by End-user
5.2 Japan Continuous Glucose Monitoring Device Market
5.2.1 Japan Continuous Glucose Monitoring Device Market by Component
5.2.2 Japan Continuous Glucose Monitoring Device Market by End-user
5.3 India Continuous Glucose Monitoring Device Market
5.3.1 India Continuous Glucose Monitoring Device Market by Component
5.3.2 India Continuous Glucose Monitoring Device Market by End-user
5.4 South Korea Continuous Glucose Monitoring Device Market
5.4.1 South Korea Continuous Glucose Monitoring Device Market by Component
5.4.2 South Korea Continuous Glucose Monitoring Device Market by End-user
5.5 Singapore Continuous Glucose Monitoring Device Market
5.5.1 Singapore Continuous Glucose Monitoring Device Market by Component
5.5.2 Singapore Continuous Glucose Monitoring Device Market by End-user
5.6 Malaysia Continuous Glucose Monitoring Device Market
5.6.1 Malaysia Continuous Glucose Monitoring Device Market by Component
5.6.2 Malaysia Continuous Glucose Monitoring Device Market by End-user
5.7 Rest of Asia Pacific Continuous Glucose Monitoring Device Market
5.7.1 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by Component
5.7.2 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by End-user
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental & Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals:
6.6 Ypsomed AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 GlySens, Incorporated
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
6.10.1 Company Overview
6.11 Johnson and Johnson
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Segmental &Regional Analysis
6.11.4 Research & Development Expenses
6.11.5 Recent strategies and developments:
6.11.5.1 Approvals:
TABLE 1 Asia Pacific Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 2 Asia Pacific Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 3 Asia Pacific Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 4 Asia Pacific Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 5 Asia Pacific Sensors Market by Country, 2016 - 2019, USD Million
TABLE 6 Asia Pacific Sensors Market by Country, 2020 - 2026, USD Million
TABLE 7 Asia Pacific Transmitters Market by Country, 2016 - 2019, USD Million
TABLE 8 Asia Pacific Transmitters Market by Country, 2020 - 2026, USD Million
TABLE 9 Asia Pacific Receivers Market by Country, 2016 - 2019, USD Million
TABLE 10 Asia Pacific Receivers Market by Country, 2020 - 2026, USD Million
TABLE 11 Asia Pacific Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 12 Asia Pacific Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 13 Asia Pacific Hospitals Continuous Glucose Monitoring Device Market by Country, 2016 - 2019, USD Million
TABLE 14 Asia Pacific Hospitals Continuous Glucose Monitoring Device Market by Country, 2020 - 2026, USD Million
TABLE 15 Asia Pacific Homecare Settings Market by Country, 2016 - 2019, USD Million
TABLE 16 Asia Pacific Homecare Settings Market by Country, 2020 - 2026, USD Million
TABLE 17 Asia Pacific Other End Users Market by Country, 2016 - 2019, USD Million
TABLE 18 Asia Pacific Other End Users Market by Country, 2020 - 2026, USD Million
TABLE 19 Asia Pacific Continuous Glucose Monitoring Device Market by Country, 2016 - 2019, USD Million
TABLE 20 Asia Pacific Continuous Glucose Monitoring Device Market by Country, 2020 - 2026, USD Million
TABLE 21 China Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 22 China Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 23 China Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 24 China Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 25 China Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 26 China Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 27 Japan Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 28 Japan Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 29 Japan Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 30 Japan Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 31 Japan Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 32 Japan Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 33 India Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 34 India Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 35 India Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 36 India Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 37 India Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 38 India Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 39 South Korea Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 40 South Korea Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 41 South Korea Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 42 South Korea Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 43 South Korea Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 44 South Korea Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 45 Singapore Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 46 Singapore Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 47 Singapore Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 48 Singapore Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 49 Singapore Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 50 Singapore Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 51 Malaysia Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 52 Malaysia Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 53 Malaysia Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 54 Malaysia Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 55 Malaysia Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 56 Malaysia Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 57 Rest of Asia Pacific Continuous Glucose Monitoring Device Market, 2016 - 2019, USD Million
TABLE 58 Rest of Asia Pacific Continuous Glucose Monitoring Device Market, 2020 - 2026, USD Million
TABLE 59 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by Component, 2016 - 2019, USD Million
TABLE 60 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by Component, 2020 - 2026, USD Million
TABLE 61 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by End-user, 2016 - 2019, USD Million
TABLE 62 Rest of Asia Pacific Continuous Glucose Monitoring Device Market by End-user, 2020 - 2026, USD Million
TABLE 63 Key Information – Abbott Laboratories
TABLE 64 Key Information – Medtronic PLC
TABLE 65 key information – F. Hoffmann-La Roche Ltd.
TABLE 66 Key information – Novo Nordisk A/S
TABLE 67 Key Information – DexCom, Inc.
TABLE 68 Key Information –-Ypsomed AG
TABLE 69 Key Information – Senseonics Holdings, Inc.
TABLE 70 Key Information – GlySens, Incorporated
TABLE 71 Key information – A. Menarini Diagnostics Ltd.
TABLE 72 Key Information – Echo Therapeutics, Inc.
TABLE 73 Key information –Johnson and Johnson
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Abbott Laboratories
FIG 3 Recent strategies and developments: Medtronic PLC
FIG 4 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 5 Recent strategies and developments: Novo Nordisk A/S